✦ LIBER ✦

3561 POSTER A prospective study for serum REG4 protein in pancreatic cancer as a tumor marker

✍ Scribed by A. Sawaki; R. Takayama; N. Mizuno; M. Tajika; N. Hoki; Z. Sayed; K. Matsuo; H. Nakagawa; Y. Nakamura; K. Yamao

Book ID: 118625906
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 78 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)71064-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum tissue polypeptide antigen (S-TPA)

Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study

✍ C. Maulard; M. E. Toubert; Y. Chretien; S. Delanian; B. Dufour; M. Housset 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

Proteomics-based identification of DEAD-

Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer

✍ Qing Xia; Xian-Tao Kong; Guo-An Zhang; Xiao-Jin Hou; Hua Qiang; Ren-Qian Zhong 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Serum ca 50 as a tumor marker in pancrea

Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9

✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different

Assessment of Serum Platelet Factor 4 as

Assessment of Serum Platelet Factor 4 as a Predictive Marker for VTE and as a Prognostic Biomarker in Pancreatic, Colorectal, Breast, and Lung Cancer

✍ K.E. Poruk; M.A. Firpo; K.M. Boucher; W.L. Akerley; L.A. Neumayer; B. Sklow; C.L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Assessment of circulating tumor cells an

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

✍ François-Clément Bidard; David Hajage; Thomas Bachelot; Suzette Delaloge; Etienn 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 313 KB

353 Assessment of Circulating Tumor Cell

353 Assessment of Circulating Tumor Cells and Serum Markers for Progression-free Survival Prediction in Metastatic Breast Cancer: a Prospective Observational Study

✍ J.Y. Pierga; D. Hajage; T. Bachelot; S. Delaloge; E. Brain; M. Campone; P.H. Cot 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB